Cargando…
Aberrant DNA hydroxymethylation reshapes transcription factor binding in myeloid neoplasms
Epigenetic abnormalities in DNA hydroxymethylation (5hmC) have been detected in patients with myeloid neoplasms, suggesting that 5hmC might act as a valuable epigenetic mark to reflect the disease status of myeloid neoplasms. Here, we report systematic genome-wide mapping of the DNA hydroxymethylome...
Autores principales: | Li, Jia, Hong, Tingting, Wei, Yue, Guo, Lei, Lee, Minjung, Yang, Hui, Class, Caleb, Yang, Yaling, Wang, Xiaoqiong, He, Hua, Siwko, Stefan, You, M. James, Zhou, Yubin, Garcia-Manero, Guillermo, Huang, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241241/ https://www.ncbi.nlm.nih.gov/pubmed/35765052 http://dx.doi.org/10.1186/s13148-022-01297-5 |
Ejemplares similares
-
Aberrantly hydroxymethylated differentially expressed genes and the associated protein pathways in osteoarthritis
por: Fang, Yang, et al.
Publicado: (2019) -
Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms
por: Guo, Hao, et al.
Publicado: (2022) -
Decoding the dynamic DNA methylation and hydroxymethylation landscapes in endodermal lineage intermediates during pancreatic differentiation of hESC
por: Li, Jia, et al.
Publicado: (2018) -
Concurrent Mutations in SF3B1 and PHF6 in Myeloid Neoplasms
por: Zuo, Zhuang, et al.
Publicado: (2022) -
Alpha-Deoxyguanosine to Reshape the Alpha-Thrombin Binding Aptamer
por: Kolganova, Natalia A., et al.
Publicado: (2023)